{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:13:03Z","timestamp":1771038783592,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R010307\/1"],"award-info":[{"award-number":["MR\/R010307\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J014508\/1"],"award-info":[{"award-number":["BB\/J014508\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008459","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T17:30:28Z","timestamp":1594834228000},"page":"e0008459","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C"],"prefix":"10.1371","volume":"14","author":[{"given":"Federico","family":"Napolitano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Merone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ammendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-8678","authenticated-orcid":true,"given":"Emma","family":"Horncastle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lanzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Maria","family":"Contino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Sbrocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sommella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-4628","authenticated-orcid":true,"given":"Joshua D.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jospeh","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-4993","authenticated-orcid":true,"given":"Richard A.","family":"Urbanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Lahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Folgori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan K.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Wizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-7634","authenticated-orcid":true,"given":"Alessandra","family":"Vitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"pntd.0008459.ref001","volume-title":"Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases","author":"World Health Organization, Savioli L, Daumerie D, World Health Organization. Department of Control of Neglected Tropical Diseases","year":"2013"},{"issue":"6","key":"pntd.0008459.ref002","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.coviro.2011.10.014","article-title":"A perspective on lyssavirus emergence and perpetuation","volume":"1","author":"CE Rupprecht","year":"2011","journal-title":"Curr Opin Virol"},{"issue":"9","key":"pntd.0008459.ref003","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0264-410X(91)90188-C","article-title":"The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines","volume":"9","author":"PS Wunderli","year":"1991","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0008459.ref004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.01.003","article-title":"Current and future approaches to the therapy of human rabies","volume":"99","author":"AC Jackson","year":"2013","journal-title":"Antiviral Res"},{"issue":"18","key":"pntd.0008459.ref005","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.vaccine.2013.12.031","article-title":"Rabies: underused vaccines, unnecessary deaths","volume":"32","author":"B Dodet","year":"2014","journal-title":"Vaccine"},{"key":"pntd.0008459.ref006","unstructured":"WHO Expert Consultation on Rabies, third report. Geneva: World Health Organization; 2018 (WHO Technical Report Series, No. 1012). Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"37","key":"pntd.0008459.ref007","first-page":"5500","article-title":"Rabies vaccines: WHO position paper","volume":"36","author":"O. World Health","year":"2018","journal-title":"April 2018\u2014Recommendations. Vaccine"},{"issue":"115","key":"pntd.0008459.ref008","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"S Colloca","year":"2012","journal-title":"Sci Transl Med"},{"issue":"12","key":"pntd.0008459.ref009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1080\/14760584.2017.1394842","article-title":"Chimpanzee adenoviral vectors as vaccines\u2014challenges to move the technology into the fast lane","volume":"16","author":"A Vitelli","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"pntd.0008459.ref010","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"N Tatsis","year":"2007","journal-title":"Blood"},{"issue":"4","key":"pntd.0008459.ref011","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/hum.2014.007","article-title":"Challenges in manufacturing adenoviral vectors for global vaccine product deployment","volume":"25","author":"J Vellinga","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"3","key":"pntd.0008459.ref012","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"SM Moore","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"3","key":"pntd.0008459.ref013","doi-asserted-by":"crossref","first-page":"e55435","DOI":"10.1371\/journal.pone.0055435","article-title":"Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.","volume":"8","author":"A Vitelli","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"pntd.0008459.ref014","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/jps.20157","article-title":"Development of stable liquid formulations for adenovirus-based vaccines","volume":"93","author":"RK Evans","year":"2004","journal-title":"J Pharm Sci"},{"key":"pntd.0008459.ref015","volume-title":"Structural Approaches to Sequence Evolution Biological and Medical Physics","author":"Springer B, Heidelberg","year":"2007"},{"issue":"51","key":"pntd.0008459.ref016","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1016\/j.vaccine.2009.09.024","article-title":"A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa","volume":"27","author":"E Wright","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"pntd.0008459.ref017","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2016.10.013","article-title":"Human Adaptation of Ebola Virus during the West African Outbreak","volume":"167","author":"RA Urbanowicz","year":"2016","journal-title":"Cell"},{"issue":"1","key":"pntd.0008459.ref018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1099\/0022-1317-48-1-97","article-title":"Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. I. The nucleocapsid protein","volume":"48","author":"A Flamand","year":"1980","journal-title":"J Gen Virol"},{"issue":"1","key":"pntd.0008459.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.1830210102","article-title":"T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides","volume":"21","author":"HC Ertl","year":"1991","journal-title":"Eur J Immunol"},{"issue":"5","key":"pntd.0008459.ref020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt1087","article-title":"Stable antibody expression at therapeutic levels using the 2A peptide","volume":"23","author":"J Fang","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"4","key":"pntd.0008459.ref021","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"R Zufferey","year":"1999","journal-title":"J Virol"},{"issue":"3","key":"pntd.0008459.ref022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15376510802312464","article-title":"Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts","volume":"5","author":"RL Sheets","year":"2008","journal-title":"J Immunotoxicol"},{"key":"pntd.0008459.ref023","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"CE Rupprecht","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"pntd.0008459.ref024","unstructured":"Global elimination of dog-mediated human rabies: report of the Rabies Global Conference, Geneva, Switzerland, 10\u201311 December 2015. 2016."},{"key":"pntd.0008459.ref025","first-page":"213","article-title":"The Pan American Health Organization (PAHO) role in the control of rabies in Latin America","volume":"119","author":"AJ Belotto","year":"2004","journal-title":"Dev Biol (Basel)"},{"issue":"4","key":"pntd.0008459.ref026","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3201\/eid1904.121482","article-title":"Rabies update for Latin America and the Caribbean","volume":"19","author":"MA Vigilato","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"pntd.0008459.ref027","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1371\/journal.pntd.0000243","article-title":"Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab')(2) fragment rabies immunoglobulin (Favirab)","volume":"2","author":"BP Quiambao","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0008459.ref028","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"JA Kessels","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"9","key":"pntd.0008459.ref029","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"P Chulasugandha","year":"2006","journal-title":"Vaccine"},{"key":"pntd.0008459.ref030","article-title":"New human rabies vaccines in the pipeline","author":"AR Fooks","year":"2018","journal-title":"Vaccine"},{"issue":"10101","key":"pntd.0008459.ref031","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"M Alberer","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"pntd.0008459.ref032","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"DR Casimiro","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"pntd.0008459.ref033","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa","volume":"12","author":"Z Xiang","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"pntd.0008459.ref034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.virol.2013.12.029","article-title":"Protection of non-human primates against rabies with an adenovirus recombinant vaccine","volume":"450\u2013451","author":"ZQ Xiang","year":"2014","journal-title":"Virology"},{"issue":"10","key":"pntd.0008459.ref035","doi-asserted-by":"crossref","first-page":"e0006870","DOI":"10.1371\/journal.pntd.0006870","article-title":"A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis","volume":"12","author":"C Wang","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0008459.ref036","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"KM Quinn","year":"2015","journal-title":"J Clin Invest"},{"issue":"2","key":"pntd.0008459.ref037","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"SE Hensley","year":"2007","journal-title":"Mol Ther"},{"issue":"35","key":"pntd.0008459.ref038","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.vaccine.2010.06.050","article-title":"Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28","volume":"28","author":"CA Kahl","year":"2010","journal-title":"Vaccine"},{"issue":"18","key":"pntd.0008459.ref039","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"JE Teigler","year":"2012","journal-title":"J Virol"},{"issue":"9","key":"pntd.0008459.ref040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"MD Dicks","year":"2015","journal-title":"Vaccine"},{"issue":"11\u201312","key":"pntd.0008459.ref041","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0264-410X(98)00357-0","article-title":"Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?","volume":"17","author":"A Drings","year":"1999","journal-title":"Vaccine"},{"issue":"24","key":"pntd.0008459.ref042","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1073\/pnas.84.24.9165","article-title":"Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein","volume":"84","author":"B Dietzschold","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pntd.0008459.ref043","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.66.5.2601-2604.1992","article-title":"Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein","volume":"66","author":"M Fekadu","year":"1992","journal-title":"J Virol"},{"issue":"6","key":"pntd.0008459.ref044","doi-asserted-by":"crossref","first-page":"e0004746","DOI":"10.1371\/journal.pntd.0004746","article-title":"An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs","volume":"10","author":"M Schnee","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008459.ref045","article-title":"First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults","author":"P Cicconi","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0008459.ref046","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4161\/21645515.2014.972741","article-title":"Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species","volume":"10","author":"C Malerczyk","year":"2014","journal-title":"Hum Vaccin Immunother"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009348","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T17:31:20Z","timestamp":1594834280000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008459"}},"subtitle":[],"editor":[{"given":"Amy T.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008459","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009348","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]}}}